S.F. Company Raises $10K in Crowdfunding Campaign To Test Potential Ebola Treatment
On Friday, a San Francisco-based company announced that its crowdfunding campaign to finance research into a potential Ebola treatment reached its $10,000 goal. OncoSynergy plans to start preclinical work to test whether its experimental cancer treatment can also be used to treat Ebola.
"Potential Ebola Treatment Finds Backers in Crowd-Funded Campaign" (Leuty, "BiotechSF," San Francisco Business Times, 9/22).This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.